Atherosclerosis in survivors of Kawasaki disease

J Pediatr. 2009 Oct;155(4):572-7. doi: 10.1016/j.jpeds.2009.04.054.

Abstract

Objectives: To test the hypothesis that long-term survivors of low-risk Kawasaki disease (KD) have ongoing vascular inflammation and dysfunction and a higher risk of accelerated atherosclerosis than healthy control subjects.

Study design: Twenty-eight patients with KD (7-20 years after acute illness) and 27 age-matched healthy control subjects were examined for medical and dietary history, serum markers of atherosclerotic risk and inflammation, carotid intimal-medial thickness (CIMT) with vascular ultrasound scanning and arterial stiffness with applanation tonometry.

Results: Patients and control subjects were similar in age, sex, body mass index, waist-to-hip ratio, blood pressure, cigarette smoking, family history, diet, high-density lipoprotein cholesterol level, lipoprotein (a) level, homocysteine level, glucose level, insulin level, CIMT, arterial stiffness, C-reactive protein level, and inflammatory cytokine level. Levels of total cholesterol and apolipoprotein B were significantly higher in patients with KD than in control subjects.

Conclusions: There was no evidence of increased atherosclerosis. Small but significant differences in cholesterol and apolipoprotein B levels could suggest increased future risk for atherosclerosis and warrant further study.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute-Phase Proteins / metabolism
  • Adolescent
  • Adult
  • Atherosclerosis / diagnosis
  • Atherosclerosis / epidemiology*
  • Biomarkers / metabolism
  • Carotid Arteries / pathology
  • Case-Control Studies
  • Cytokines / blood
  • Female
  • Humans
  • Inflammation Mediators / blood
  • Lipids / blood
  • Male
  • Mucocutaneous Lymph Node Syndrome / complications
  • Mucocutaneous Lymph Node Syndrome / metabolism*
  • Mucocutaneous Lymph Node Syndrome / pathology*
  • Risk Factors
  • Young Adult

Substances

  • Acute-Phase Proteins
  • Biomarkers
  • Cytokines
  • Inflammation Mediators
  • Lipids